Register entry

HAS Healthcare Advanced Synthesis SA

Registered sites
1
Drug products
11
Live patents
0
Countries
1
Base
Switzerland
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufactureFinished drug manufacture
Sites

Facilities

1
SiteLocationOperationsFEI
HAS Healthcare Advanced Synthesis SABiascaSwitzerlandAnalytical testing, Active ingredient (API) manufacture, Finished drug manufacture3002807151
Catalogue

Marketed products

11

Showing 11 of 11.

BrandGeneric nameFormCategory
-Anamorelin HydrochloridePOWDERBULK INGREDIENT
-BexarotenePOWDERBULK INGREDIENT
-CarfilzomibPOWDER, FOR SOLUTIONBULK INGREDIENT
-CrinecerfontPOWDERBULK INGREDIENT
-Cysteamine HydrochloridePOWDERBULK INGREDIENT
-Dantrolene SodiumPOWDERBULK INGREDIENT
-Glycerol PhenylbutyrateLIQUIDBULK INGREDIENT
-Glycerol PhenylbutyrateLIQUIDBULK INGREDIENT
-IsotretinoinPOWDERBULK INGREDIENT
-Lofexidine HydrochloridePOWDERBULK INGREDIENT
-Palonosetron HydrochloridePOWDERBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.